Image

Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty

Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Prospective, multinational pilot study for evaluation of the Pheno4U data platform in Total Knee Arthroplasty (TKA) patients

Description

The study will collect data for each patient receiving an Aesculap Total Knee Arthroplasty (TKA) implant. The data set will be analyzed for critical risk factors among implant and patient data in order to optimize patient-centered therapies.

The products under investigation will be used in routine clinical practice and according to the Instructions for Use (IFU). Data obtained in routine clinical use will be collected in the Pheno4U data platform. In addition, patients are expected to answer questionnaires about their health status. Furthermore, patients are asked to use the so called "BPMpathway" sensor and application in order to measure the active Range of Motion (ROM). The sensor can also be used for pre- and postoperative training .

Eligibility

Inclusion Criteria:

  • Patient undergoing a total knee arthroplasty with a B. Braun knee implant system
  • Signed written informed consent
  • Patient's willingness & ability to use the "BPMpathway"sensor
  • Patient's willingness & ability to use the "4Patient" application

Exclusion Criteria:

  • Patient age < 18 years
  • Patient not willing to participate at the further follow-up
  • Pregnancy
  • If intraoperatively an implant from a different manufacturer is used, the study patient has to be excluded from the study.

Study details
    Degenerative Osteoarthritis
    Rheumatoid Arthritis
    Posttraumatic Arthropathy
    Chronic Instability of Knee
    Stiffness of Knee
    Deformity Knee

NCT05302934

Aesculap AG

26 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.